Peritoneal dialysis-related peritonitis caused by Mycobacterium iranicum: A case report and literature review.

Authors

Hirotaka Yamashita, Daisuke Ono, Kazuyuki Mimura, Kunihisa Tsukada, Hideaki Oka

Published in

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. Pages 103071. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Mycobacterium iranicum is an emerging scotochromogenic, rapidly growing mycobacterium (RGM) known to cause infections in multiple organ systems. However, because only a limited number of M. iranicum infections have been reported, optimal treatments have not been established. Here, we describe the case of a man in his 80s who developed peritoneal dialysis (PD)-related peritonitis caused by M. iranicum. Dialysate cultures yielded RGM, which was subsequently identified as M. iranicum using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. After PD catheter removal, a multidrug regimen comprising amikacin, meropenem, and azithromycin was initiated. To assess inducible macrolide resistance, antimicrobial susceptibility testing with 14 days of incubation was performed, confirming macrolide susceptibility. The patient transitioned to oral azithromycin and levofloxacin and completed a 3-month course without recurrence. To our knowledge, this is the first reported case of M. iranicum PD-related peritonitis treated with an azithromycin-containing regimen. The literature review suggests that, although M. iranicum may show in vitro susceptibility to several agents used for RGM infections, the detection of the plasmid-borne erm(55) gene in M. iranicum warrants caution when interpreting macrolide susceptibility results. Macrolide susceptibility was evaluated through 14 days in this case; however, resistance genes were not assessed, and the contribution of azithromycin cannot be determined given catheter removal and other antimicrobials. In conclusion, this case illustrates that M. iranicum can cause PD-related peritonitis that may require catheter removal and individualized antimicrobial therapy. Further studies are needed to determine optimal treatment, including individual roles of agents in combination therapy, for M. iranicum infections.

PMID:
42727808
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.